Please assess the completion status of the following clinical trial:

Trial Title: A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Successfully completed Study ICA-17043-10~* Discontinued Study 10 or 12 following the DMC recommendations because he/she was not on HU, and has since been on a stable dose of HU for at least 3 months prior to Day 1~* Male, or female not capable of becoming pregnant or using appropriate birth control~* Has willingly given written informed consent to participate in this study~Exclusion Criteria:~* The subject, if female, has a positive urine pregnancy test on Day 1 (before entering study)~* The subject is presently unsuitable for participation in this long-term study

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: 66 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).